Clinical Trials Directory

Trials / Completed

CompletedNCT02127944

Assessment of Ovarian Reserve Tests in Unexplained Infertile Women

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Karadeniz Technical University · Academic / Other
Sex
Female
Age
21 Years – 35 Years
Healthy volunteers
Accepted

Summary

IN UNEXPLAINED INFERTILITY IN WOMEN ,OVARY RESERVE IS BORDERLINE IF ASSESSED USING HIGH-SENSITIVE TESTS.

Detailed description

IN UNEXPLAINED INFERTILITY OVARIAN RESERVE TESTS WERE ASSESSED. IN THIS STUDY, A COMPARISON IS DONE BETWEEN 35 WOMEN WITH UNEXPLAINED FERTILITY(THE PATIENT) AND 35 WOMEN WHO DON'T HAVE ANY FERTILITY PROBLEMS AND HAVE AT LEAST A CHILD (THE CONTROL GROUP). THE STUDY PARTICIPANTS SHOULD HAVE THE FOLLOWING CRITERIA Inclusion Criteria: LESS THAN 35 YEARS OLD, MARRIED WOMEN SHOULD HAVE REGULAR MENSES SHOULD HAVE AT LEAST A YEAR OF UNPROTECTED SEX. THE HUSBAND'S SPERMOGRAM SHOULD HAVE NO ABNORMALITIES THE SUBJECT SHOULD HAVE A NORMAL HYSTEROSALPHINGOGRAPHY Exclusion Criteria: HAVING ANY SYSTEMIC DISEASE. LONG HISTORY OF ANY DRUG USAGE. FOR THE CONTROL GROUP Inclusion Criteria: LESS THAN 35 YEARS OLD, MARRIED WOMEN SHOULD HAVE REGULAR MENSES AT LEAST HAVE A CHILD THE HUSBAND'S SPERMOGRAM SHOULD HAVE NO ABNORMALITIES THE SUBJECT SHOULD HAVE A NORMAL HYSTEROSALPHINGOGRAPHY Exclusion Criteria: HAVING ANY SYSTEMIC DISEASE. LONG HISTORY OF ANY DRUG USAGE. THE STUDY INCLUDES THE FOLLOWING TESTS BEING DONE ON THE PATIENTS: THE FOLLOWING HORMONES' LEVELS WERE STUDIED:AMH (ANTI-MULLERIAN HORMONE),FSH (FOLLICULAR STIMULATING HORMONE) , E2 (ESTRADIOL) AND INHIBIN B.THE FORMER THREE HORMONE LEVELS SHOULD BE ASSESSED ON THE THIRD DAY OF MENSES IN THE STUDY,TRANSVAGINAL ULTRASONOGRAPHIC OVARIAN VOLUME ,OVARIAN ANTRAL FOLLICULE NUMBER,OVARIAN STROMAL BLOODFLOW AND OVARIAN ARTERIAL RESISTANCE WAS MEASURED USING DOPPLER ULTRASONOGRAM.

Conditions

Timeline

Start date
2014-04-01
Primary completion
2015-06-01
Completion
2015-07-01
First posted
2014-05-01
Last updated
2018-12-07

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02127944. Inclusion in this directory is not an endorsement.